Literature DB >> 3670389

Growth inhibition by protein kinase C late in mitogenesis.

C L Huang1, H E Ives.   

Abstract

The importance of alpha-thrombin in the clotting cascade is well-known, but it is also a potent mitogen. Like many other mitogens, thrombin causes receptor-mediated activation of a phosphatidylinositol-specific phospholipase C (PLC), leading to the release of diacylglycerol and the subsequent activation of protein kinase C (refs 3-6). Protein kinase C is probably important in cell proliferation, as activation of this enzyme by phorbol esters promotes growth in many systems. Some growth factors have tyrosine kinase activity and function without activation of PLC or protein kinase C. In this report we show that alpha-thrombin retains its mitogenicity in vascular smooth muscle cells depleted of protein kinase C. Phorbol-12-myristate-13-acetate (PMA) is found to be a potent growth inhibitor when added to vascular smooth muscle cells with alpha-thrombin. Moreover, growth inhibition is maximal when protein kinase C is activated 4 hours after exposure to thrombin, long after the completion of 'early events' induced by thrombin. Thus, PMA probes an event late in the G1 phase of the cell cycle or at the G1-S transition.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3670389     DOI: 10.1038/329849a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  17 in total

1.  Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

Authors:  G P Gasic; C P Arenas; T B Gasic; G J Gasic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  A protein kinase C isozyme is translocated to cytoskeletal elements on activation.

Authors:  D Mochly-Rosen; C J Henrich; L Cheever; H Khaner; P C Simpson
Journal:  Cell Regul       Date:  1990-08

3.  Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene.

Authors:  M Satake; T Ibaraki; Y Yamaguchi; Y Ito
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo.

Authors:  J E Pawlowski; D S Taylor; M Valentine; M E Hail; P Ferrer; M C Kowala; C J Molloy
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

5.  Low diacylglycerol values in colonic adenomas and colorectal cancer.

Authors:  G Sauter; A Nerlich; U Spengler; R Kopp; A Pfeiffer
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

6.  Thrombin-stimulated events in cultured vascular smooth-muscle cells.

Authors:  B C Berk; M B Taubman; K K Griendling; E J Cragoe; J W Fenton; T A Brock
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

7.  Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin.

Authors:  D S Taylor; X Cheng; J E Pawlowski; A R Wallace; P Ferrer; C J Molloy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Vasopressin stimulates phospholipase D activity against phosphatidylcholine in vascular smooth muscle cells.

Authors:  C J Welsh; K Schmeichel; H T Cao; H Chabbott
Journal:  Lipids       Date:  1990-11       Impact factor: 1.880

9.  Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation.

Authors:  M B Taubman; J D Marmur; C L Rosenfield; A Guha; S Nichtberger; Y Nemerson
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

10.  Protein kinase C (PKC) activity and PKC messenger RNAs in human pituitary adenomas.

Authors:  L Jin; T Maeda; W F Chandler; R V Lloyd
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.